| Sandoz Pharmaceuticals AG - Dailiport 5 mg, Retardkapseln | | 67285 | | 05 | | Dailiport 5 mg | | Retardkapseln | | L04AD02 | | Tacrolimus | | 28.05.2020 | | |
| | Composition | | tacrolimusum 5 mg ut tacrolimusum monohydricum, color.: E 110, E 127, E 129, E 133, excipiens pro capsula. | | Packungsbestandteile | | Delayed release capsules | | | | | | Active Agent | Dose |
|---|
| Tacrolimus | 5 mg |
| | | | Inactive agents | | additional_information |
|---|
| E 110 | | color. | | E 127 | | color. | | E 129 | | color. | | E 133 | | color. |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
